| Name | Pascolizumab |
|---|
| Description | Pascolizumab (SB-240683) is a humanized anti-IL-4 monoclonal antibody. Pascolizumab has the potential for the research of asthma[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Pascolizumab 结合 IL-4 可抑制 IL-4 与 IL-4 受体的 α 链相互作用[1]。 Pascolizumab (0-10000 pM; 3 days) 显示出抗增殖活性,对 T 细胞和扁桃体 B 细胞的 IC50 值分别为 157、377 pM[1]。 Cell Proliferation Assay[1] Cell Line: human or monkey T cells Concentration: 0-10000 pM Incubation Time: 3 days Result: Inhibited the response of human and monkey T cells to recombinant monkey IL-4 (2 ng/ml) with IC50 values of 268 pM and 587 pM, respectively. |
| References |
| No Any Chemical & Physical Properties |